Upper limb lymphedema after breast cancer. Postmastectomy lymphedema syndrome
Conditions
Interventions
Intervention 1: Control group: The Complete Decongestive Therapy of lymphedema is given to the patient which includes: Manual lymphatic Drainage , exercises (stretching and proprioceptive neuromuscula
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
32 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with breast cancer who had axillary lymph node surgery with and without radiotherapy or taxane chemotherapy or unilateral mastectomy First-degree unilateral lymphedema according to the lymphology assembly Age 32 to 80 years Body mass index less than 30 The difference in the measured points between two organs should be between 2 and 8 cm at least in one point of the organ
Exclusion criteria
Exclusion criteria: Infection in the operated area Lymphatic vessel inflammation or deep vein occlusion History of chronic respiratory disease Receiving other treatments at the same time as the study treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before, immediately and one month after the treatment. Method of measurement: Visual Analog Scale.;Circumference size of upper limb. Timepoint: Before, immediately and one month after the treatment. Method of measurement: meter.;Vital Capacity of breathing(VC) (Volumetric lung function test). Timepoint: Before, immediately and one month after the treatment. Method of measurement: Spirometer.;Forced Vital Capacity of breathing(FVC) (Volumetric lung function test). Timepoint: Before, immediately and one month after the treatment. Method of measurement: Spirometer.;Breathing Forced Expiratory Volume in First second(FEV1) (Volumetric lung function test). Timepoint: Before, immediately and one month after the treatment. Method of measurement: Spirometer.;End-expiratory carbon dioxide concentration(End Tidal CO2) (biochemical lung function test). Timepoint: Before, immediately and one month after the treatment. Method of measurement: capnograph.;Arterial oxygen concentration(PaO2) (biochemical lung function test). Timepoint: Before, immediately and one month after the treatment. Method of measurement: capnograph.;Respiratory rate (biochemical lung function test). Timepoint: Before, immediately and one month after the treatment. Method of measurement: capnograph.;Arterial carbon dioxide pressure(PaCO2) (biochemical lung function test). Timepoint: Before, immediately and one month after the treatment. Method of measurement: capnograph. | — |
Secondary
| Measure | Time frame |
|---|---|
| Range Of Motion(ROM). Timepoint: Before the intervention, immediately and one month after the end of the intervention. Method of measurement: Goniometer.;Quality Of Life(QOL). Timepoint: Before the intervention, immediately and one month after the end of the intervention. Method of measurement: lymphedema life impact scale Questionnaire (LLIS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArefe Fattah
Ahvaz University of Medical Sciences
Outcome results
None listed